Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 9/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1499940 | 1.00 | SMPD1 (0.43) | SMPD1FDPSGGPS1CES2MEN1 | |
| SCHEMBL4105971 | 1.00 | SMPD1 (0.43) | SMPD1FDPSGGPS1CES2MEN1 | |
| SCHEMBL7538243 | 1.00 | SMPD1 (0.43) | SMPD1FDPSGGPS1CES2MEN1 | |
| SCHEMBL1064519 | 1.00 | SMPD1 (0.43) | SMPD1FDPSGGPS1CES2MEN1 | |
| SCHEMBL7537623 | 1.00 | SMPD1 (0.43) | SMPD1FDPSGGPS1CES2MEN1 | |
| SCHEMBL2306623 | 0.98 | FDPS (0.41) | SMPD1FDPSGGPS1CES2MEN1 | |
| SCHEMBL7065275 | 0.90 | HRH3 (0.48) | MEN1MAPTKMT2AATM | |
| SCHEMBL7064542 | 0.90 | HRH3 (0.48) | MEN1MAPTKMT2AATM | |
| SCHEMBL632822 | 0.90 | HRH3 (0.48) | MEN1MAPTKMT2AATM | |
| SCHEMBL7066229 | 0.90 | HRH3 (0.48) | MEN1MAPTKMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103445975-B | Emulsification cosmetic composition | 花王株式会社 | 2017-08-22 | — | — | CN | claimed |
| JP-9295994-A | — | — | None | — | — | JP | disclosed |
| CN-114432169-A | Multi-layer detergent composition and method of use thereof | 花王株式会社 | 2022-05-06 | — | — | CN | disclosed |
| US-20220110906-A1 | ANTIMICROBIAL DENTAL APPLIANCE | 3M INNOVATIVE PROPERTIES COMPANY | 2022-04-14 | — | — | US | disclosed |
| EP-3003718-B1 | SUCCESSIVELY PEELABLE COEXTRUDED POLYMER FILM WITH EMBEDDED ANTIMICROBIAL LAYER(S) | 3M INNOVATIVE PROPERTIES CO (US) | 2021-12-29 | — | — | EP | disclosed |
| EP-3905985-A1 | ANTIMICROBIAL DENTAL APPLIANCE | 3M Innovative Properties Company (US) | 2021-11-10 | — | — | EP | disclosed |
| US-10918618-B2 | Methods of reducing microbial contamination | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-02-16 | — | — | US | disclosed |
| WO-2020141444-A1 | ANTIMICROBIAL DENTAL APPLIANCE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-07-09 | — | — | WO | disclosed |
| US-10682830-B2 | Successively peelable coextruded polymer film with embedded antimicrobial layer(s) | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-06-16 | — | — | US | disclosed |
| US-20200030276-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-01-30 | — | — | US | disclosed |
| EP-1662873-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M Innovative Properties Company (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20050089539-A1 | Antimicrobial compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2005-04-28 | — | — | US | disclosed |
| US-20050084471-A1 | Concentrated antimicrobial compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2005-04-21 | — | — | US | disclosed |
| US-20050058673-A1 | Antimicrobial compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2005-03-17 | — | — | US | disclosed |
| WO-2005023023-A1 | CONCENTRATED ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-17 | — | — | WO | disclosed |
| WO-2005022998-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-17 | — | — | WO | disclosed |
| WO-2005023233-A2 | ANTIMICROBIAL COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-17 | — | — | WO | disclosed |
| US-20050053593-A1 | Antimicrobial compositions and methods | 3M INNOVATIVE PROPERTIES COMPANY | 2005-03-10 | — | — | US | disclosed |
| JP-H09295994-A | PRODUCTION OF GLYCOSIDE COMPOUND | LION CORP | 1997-11-18 | — | — | JP | disclosed |
| US-4098713-A | Detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10918618-B2 | Methods of reducing microbial contamination | LPO, CAT, UNG | SMPD1 383/4885FDPS 2113/4885GGPS1 2378/4885 |
| US-20050084471-A1 | Concentrated antimicrobial compositions and methods | SHARPIN, PIK3C3, SRM | SMPD1 137/4885FDPS 1898/4885GGPS1 2108/4885 |
| US-20220110906-A1 | ANTIMICROBIAL DENTAL APPLIANCE | MGLL, LIPA, MLEC | SMPD1 327/4885FDPS 2779/4885GGPS1 2975/4885 |
| US-10682830-B2 | Successively peelable coextruded polymer film with embedded antimicrobial layer(s) | PUF60, PCBP1, CD99 | SMPD1 1360/4885FDPS 2167/4885GGPS1 2250/4885 |
| US-20200030276-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS | FABP2, CUTA, LIPA | SMPD1 77/4885FDPS 1819/4885GGPS1 1957/4885 |
| US-20050089539-A1 | Antimicrobial compositions and methods | FABP2, CUTA, LIPA | SMPD1 77/4885FDPS 1819/4885GGPS1 1957/4885 |
| US-20050058673-A1 | Antimicrobial compositions and methods | FABP2, CUTA, LIPA | SMPD1 119/4885FDPS 2024/4885GGPS1 2354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.